Physician profile
Paul E Loethen
NPI 1053595538
$12,093.00
in general payments reported to CMS, 2019-2025
10 companies · $87.82 in 2025
The $87.82 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $23.02 · 2022: $154 · 2023: $71.88 · 2024: $642 · 2025: $87.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.16 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,748.13 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $95.01 | 2024-2025 | Gore Synecor Biomaterial |
| Davol INC. | $53.93 | 2022 | |
| Myriad Genetic Laboratories, INC. | $43.93 | 2023-2024 | Myrisk |
| Leica Microsystems INC. | $38.75 | 2019 | |
| Stryker Corporation | $23.84 | 2023 | Spy-Phi System |
| Baxter Healthcare | $23.66 | 2024 | Perclot |
| Medtronic, INC. | $23.08 | 2023 | Pteye Parathyroid Detection System |
| Ethicon US, LLC | $23.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.65 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Loethen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.